CO4940409A1 - Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior - Google Patents
Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superiorInfo
- Publication number
- CO4940409A1 CO4940409A1 CO98033551A CO98033551A CO4940409A1 CO 4940409 A1 CO4940409 A1 CO 4940409A1 CO 98033551 A CO98033551 A CO 98033551A CO 98033551 A CO98033551 A CO 98033551A CO 4940409 A1 CO4940409 A1 CO 4940409A1
- Authority
- CO
- Colombia
- Prior art keywords
- film
- dosage form
- gastrointestinal tract
- improved safety
- upper gastrointestinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/49—Cinchonan derivatives, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con una forma dedosificación oral novedosa, para ser liberada en el estómago, forma de dosificación que comprende una cantidad segura y efectiva de un ingrediente activo, Seleccionado de un grupo que comprende antibióticos de tetraciclina, preparaciones de hierro, quinidina, drogas antiinflamatorias no esteróideas, aprenolol, ácido ascórbico, capopril, teofilina, zidovudina, bifosfonatos o mezcla de estos y excipientes farmacéuticamente aceptables, en que dicha forma de dosificación oral está generalmente en forma oval y está recubierta por una película para facilitar su rápido tránsito por el esófago y para evitar irritación en la boca, la cavidad bucal, la faringe y el esófago.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4930697P | 1997-06-11 | 1997-06-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4940409A1 true CO4940409A1 (es) | 2000-07-24 |
Family
ID=21959131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO98033551A CO4940409A1 (es) | 1997-06-11 | 1998-06-11 | Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior |
Country Status (30)
Country | Link |
---|---|
US (4) | US6165513A (es) |
EP (1) | EP0989848B1 (es) |
JP (3) | JP5093937B2 (es) |
KR (1) | KR100400053B1 (es) |
CN (1) | CN1274279A (es) |
AR (1) | AR027158A1 (es) |
AT (1) | ATE277606T1 (es) |
AU (1) | AU729912B2 (es) |
BR (1) | BR9810027A (es) |
CA (1) | CA2293815C (es) |
CO (1) | CO4940409A1 (es) |
DE (1) | DE69826660T2 (es) |
DK (1) | DK0989848T3 (es) |
ES (1) | ES2226128T3 (es) |
HK (1) | HK1028187A1 (es) |
HU (1) | HUP0004625A1 (es) |
IL (2) | IL133405A0 (es) |
MY (1) | MY127526A (es) |
NO (1) | NO996116L (es) |
NZ (1) | NZ503946A (es) |
PE (1) | PE82999A1 (es) |
PL (1) | PL337813A1 (es) |
PT (1) | PT989848E (es) |
RU (1) | RU2193880C2 (es) |
SG (1) | SG108292A1 (es) |
SK (1) | SK284690B6 (es) |
TR (1) | TR200000111T2 (es) |
TW (1) | TW542725B (es) |
WO (1) | WO1998056360A2 (es) |
ZA (1) | ZA985010B (es) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0989848B1 (en) * | 1997-06-11 | 2004-09-29 | The Procter & Gamble Company | Film-coated tablet for improved upper gastrointestinal tract safety |
AR024462A1 (es) | 1999-07-01 | 2002-10-02 | Merck & Co Inc | Tabletas farmaceuticas |
US6410520B2 (en) * | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
US20060269602A1 (en) * | 2001-04-13 | 2006-11-30 | Dasch James R | Method of modifying the release profile of sustained release compositions |
US6558702B2 (en) * | 2001-04-13 | 2003-05-06 | Alkermes Controlled Therapeutics, Inc. | Method of modifying the release profile of sustained release compositions |
US20030070584A1 (en) | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
DE10129674A1 (de) * | 2001-06-20 | 2003-01-16 | Lohmann Gmbh & Co Kg | Hydrokolloidzusammensetzungen sowie deren Verwendung zur Herstellung redispergierbarer Beschichtungen, Filme, Folien oder Papiere |
US7183410B2 (en) * | 2001-08-02 | 2007-02-27 | Bidachem S.P.A. | Stable polymorph of flibanserin |
US20030060475A1 (en) * | 2001-08-10 | 2003-03-27 | Boehringer Ingelheim Pharma Kg | Method of using flibanserin for neuroprotection |
US8309118B2 (en) | 2001-09-28 | 2012-11-13 | Mcneil-Ppc, Inc. | Film forming compositions containing sucralose |
UA78974C2 (en) * | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
US20050070504A1 (en) * | 2001-12-21 | 2005-03-31 | The Procter & Gamble Co. | Risedronate compositions and their methods of use |
NZ552513A (en) | 2001-12-24 | 2008-08-29 | Teva Pharma | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
AU2003209167A1 (en) * | 2002-04-11 | 2003-10-27 | Teva Pharmaceutical Industries Ltd | Novel polymorphs and pseudopolymorphs of risedronate sodium |
US20040048877A1 (en) * | 2002-05-22 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions containing flibanserin |
EP1396263A1 (en) * | 2002-08-09 | 2004-03-10 | Warner-Lambert Company | Film coating for tablets and caplets |
US20040043072A1 (en) * | 2002-09-04 | 2004-03-04 | Will Joanne Patricia | Alleviation of upper gastrointestinal irritation |
SG174628A1 (en) * | 2002-12-20 | 2011-10-28 | Hoffmann La Roche | High dose ibandronate formulation |
TR200300510A2 (tr) * | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
CN103040773A (zh) | 2003-07-25 | 2013-04-17 | 沃纳奇尔科特有限责任公司 | 多西环素金属络合物固体剂型 |
US20050113331A1 (en) * | 2003-09-09 | 2005-05-26 | Michael Prniak | Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
NZ545804A (en) * | 2003-09-19 | 2009-09-25 | Wisconsin Alumni Res Found | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate |
WO2005046651A1 (en) * | 2003-11-12 | 2005-05-26 | Ranbaxy Laboratories Limited | Liquid filled capsules of doxycycline |
US20050181043A1 (en) * | 2004-02-12 | 2005-08-18 | Indranil Nandi | Alendronate salt tablet compositions |
US20050239798A1 (en) * | 2004-04-22 | 2005-10-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Method for the treatment of premenstrual and other female sexual disorders |
NZ551340A (en) * | 2004-04-22 | 2010-10-29 | Boehringer Ingelheim Int | Pharmaceutical composition comprising flibanserin and a melanocortin agonist for the treatment of premenstrual disorder or sexual aversion disorder |
US20050260272A1 (en) * | 2004-05-05 | 2005-11-24 | Alkermes Controlled Therapeutics, Inc. | Method of forming microparticles that include a bisphosphonate and a polymer |
WO2006020009A1 (en) * | 2004-07-23 | 2006-02-23 | The Procter & Gamble Company | Solid oral dosage form of a bisphosphonate containing a chelating agent |
US20060025420A1 (en) * | 2004-07-30 | 2006-02-02 | Boehringer Ingelheimn International GmbH | Pharmaceutical compositions for the treatment of female sexual disorders |
WO2006024471A1 (en) * | 2004-09-03 | 2006-03-09 | Boehringer Ingelheim International Gmbh | Method for the treatment of attention deficit hyperactivity disorder |
US20060062811A1 (en) * | 2004-09-21 | 2006-03-23 | Szymczak Christopher E | Medicinal cooling emulsions |
WO2006039721A2 (en) * | 2004-10-08 | 2006-04-13 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
US8012949B2 (en) * | 2004-10-08 | 2011-09-06 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS |
US20070271153A1 (en) * | 2004-12-23 | 2007-11-22 | Amit Goel | Method and system of aggregating listings for sale |
ES2588584T3 (es) * | 2005-01-21 | 2016-11-03 | Warner Chilcott Company, Llc | Un complejo metálico de tetraciclina en una forma de dosificación sólida |
WO2006096439A2 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases |
WO2006096435A1 (en) * | 2005-03-04 | 2006-09-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of depression |
EP1858515A2 (en) * | 2005-03-04 | 2007-11-28 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders |
WO2006106815A1 (ja) * | 2005-03-31 | 2006-10-12 | Takeda Pharmaceutical Company Limited | 錠剤 |
JP2008540356A (ja) * | 2005-05-06 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 薬物乱用の治療方法 |
JP2008540673A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 薬剤誘発性性機能不全の治療方法 |
JP2008540672A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 病状に起因する性的機能不全の治療方法 |
US8252776B2 (en) | 2007-04-02 | 2012-08-28 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US7541347B2 (en) | 2007-04-02 | 2009-06-02 | Medicis Pharmaceutical Coropration | Minocycline oral dosage forms for the treatment of acne |
US7919483B2 (en) * | 2005-06-24 | 2011-04-05 | Medicis Pharmaceutical Corporation | Method for the treatment of acne |
US8722650B1 (en) | 2005-06-24 | 2014-05-13 | Medicis Pharmaceutical Corporation | Extended-release minocycline dosage forms |
US20080242642A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US20080241235A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
US9192615B2 (en) | 2008-08-06 | 2015-11-24 | Medicis Pharmaceutical Corporation | Method for the treatment of acne and certain dosage forms thereof |
US7544373B2 (en) * | 2007-04-02 | 2009-06-09 | Medicis Pharmaceutical Corporation | Minocycline oral dosage forms for the treatment of acne |
JP2009503020A (ja) | 2005-08-03 | 2009-01-29 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 肥満症の治療におけるフリバンセリンの使用 |
US20070123540A1 (en) * | 2005-10-29 | 2007-05-31 | Angelo Ceci | Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
EP1945214A1 (en) * | 2005-10-29 | 2008-07-23 | Boehringer Ingelheim International GmbH | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
US20070105869A1 (en) * | 2005-11-08 | 2007-05-10 | Stephane Pollentier | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders |
US7964215B1 (en) * | 2006-01-24 | 2011-06-21 | Emet Pharmaceuticals, LLC | Delayed release dosage form |
AU2007226964B2 (en) * | 2006-03-17 | 2012-03-22 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods |
MX2008013827A (es) * | 2006-05-09 | 2008-11-10 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual. |
DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
JP2009543839A (ja) * | 2006-07-14 | 2009-12-10 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 女性の性的障害を治療するためのフリバンセリンの使用 |
JP5793828B2 (ja) * | 2006-08-14 | 2015-10-14 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | フリバンセリンの製剤及びその製造方法 |
CL2007002214A1 (es) * | 2006-08-14 | 2008-03-07 | Boehringer Ingelheim Int | Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp |
GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
CN101505736A (zh) * | 2006-08-25 | 2009-08-12 | 贝林格尔.英格海姆国际有限公司 | 控制释放系统及其制造方法 |
JP5676834B2 (ja) * | 2006-11-29 | 2015-02-25 | エスエス製薬株式会社 | 消化管への刺激性を減少した経口固形組成物 |
US20080241197A1 (en) * | 2007-04-02 | 2008-10-02 | Medicis Pharmaceutical Corporation | Minocycline dosage forms for the treatment of acne |
JP5441354B2 (ja) * | 2007-05-23 | 2014-03-12 | キヤノン株式会社 | インクセット、インクジェット記録方法、インクカートリッジ及びインクジェット記録装置 |
WO2009018834A1 (en) * | 2007-08-06 | 2009-02-12 | Pharmathen S.A. | Pharmaceutical composition containing bisphosphonate and method for the preparation thereof |
PE20091188A1 (es) | 2007-09-12 | 2009-08-31 | Boehringer Ingelheim Int | Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
PT2459176T (pt) | 2009-07-31 | 2017-12-11 | Gruenenthal Gmbh | Método de cristalização e biodisponibilidade |
EP2618827B1 (en) * | 2010-09-21 | 2021-06-02 | Intekrin Therapeutics, Inc. | Antidiabetic solid pharmaceutical compositions |
WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
US8658631B1 (en) | 2011-05-17 | 2014-02-25 | Mallinckrodt Llc | Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US9561241B1 (en) | 2011-06-28 | 2017-02-07 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for minocycline |
WO2013015599A2 (en) * | 2011-07-28 | 2013-01-31 | Yuhan Corporation | Pharmaceutical composition for oral administration comprising bisphosphonic acid or its salt |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
EP2983657B1 (en) * | 2013-04-05 | 2020-06-03 | Numedii, Inc. | Nadolol formulations for use in the treatment of inflammatory bowel disorders |
AU2015299105B2 (en) * | 2014-08-04 | 2020-10-29 | Dbv Technologies | Compositions of food allergens |
USD787042S1 (en) * | 2015-04-28 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
USD787043S1 (en) * | 2015-06-23 | 2017-05-16 | Celgene Corporation | Pharmaceutical tablet |
WO2017079350A1 (en) | 2015-11-02 | 2017-05-11 | Pura Scents, Inc. | Scent dispensation |
USD809116S1 (en) | 2015-11-02 | 2018-01-30 | Pura Scents | Dispenser |
USD816506S1 (en) | 2015-11-02 | 2018-05-01 | Pura Scents, Inc. | Vial for a scent dispenser |
US10314514B2 (en) * | 2016-05-29 | 2019-06-11 | Ankon Medical Technologies (Shanghai) Co., Ltd. | System and method for using a capsule device |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
WO2018029565A1 (en) * | 2016-08-08 | 2018-02-15 | Hetero Labs Limited | A multi-class anti-retroviral composition |
EP3496718A4 (en) | 2016-08-08 | 2020-01-22 | Hetero Labs Limited | ANTIRETROVIRAL COMPOSITIONS |
USD835257S1 (en) | 2017-02-22 | 2018-12-04 | Celgene Corporation | Pharmaceutical tablet |
USD813372S1 (en) | 2017-02-22 | 2018-03-20 | Celgene Corporation | Pharmaceutical tablet |
USD906513S1 (en) | 2019-03-19 | 2020-12-29 | Novo Nordisk A/S | Pill |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4161530A (en) * | 1975-01-06 | 1979-07-17 | Ciba-Geigy Corporation | Pharmaceutical combination preparations as hypnotics |
US4252786A (en) * | 1979-11-16 | 1981-02-24 | E. R. Squibb & Sons, Inc. | Controlled release tablet |
US4302440B1 (en) * | 1980-07-31 | 1986-08-05 | Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof | |
JPH052574Y2 (es) * | 1986-02-24 | 1993-01-22 | ||
AU622254B2 (en) * | 1989-01-03 | 1992-04-02 | Sterling Drug Inc. | Controlled-release, low dose aspirin |
NZ233403A (en) * | 1989-04-28 | 1992-09-25 | Mcneil Ppc Inc | Simulated capsule-like medicament |
PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
US5146730A (en) * | 1989-09-20 | 1992-09-15 | Banner Gelatin Products Corp. | Film-enrobed unitary-core medicament and the like |
HU227530B1 (en) * | 1991-11-22 | 2011-07-28 | Warner Chilcott Company | Delayed-release compositions containing risedronate and process for their production |
TW237386B (es) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
FR2738833B1 (fr) * | 1995-09-14 | 1997-12-05 | Seppic Sa | Composition filmogene pour le masquage de gout destinee a l'enrobage de formes solides ingerables telles qu'en particulier des comprimes pharmaceutiques |
DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
EP0989848B1 (en) * | 1997-06-11 | 2004-09-29 | The Procter & Gamble Company | Film-coated tablet for improved upper gastrointestinal tract safety |
JPH11246392A (ja) * | 1998-03-03 | 1999-09-14 | Makoto Otsuka | 経口用固形製剤 |
-
1998
- 1998-06-08 EP EP98921690A patent/EP0989848B1/en not_active Revoked
- 1998-06-08 DK DK98921690T patent/DK0989848T3/da active
- 1998-06-08 JP JP50196099A patent/JP5093937B2/ja not_active Expired - Lifetime
- 1998-06-08 SK SK1718-99A patent/SK284690B6/sk not_active IP Right Cessation
- 1998-06-08 PL PL98337813A patent/PL337813A1/xx not_active Application Discontinuation
- 1998-06-08 NZ NZ503946A patent/NZ503946A/xx not_active IP Right Cessation
- 1998-06-08 HU HU0004625A patent/HUP0004625A1/hu not_active Application Discontinuation
- 1998-06-08 ES ES98921690T patent/ES2226128T3/es not_active Expired - Lifetime
- 1998-06-08 IL IL13340598A patent/IL133405A0/xx unknown
- 1998-06-08 CN CN98806116A patent/CN1274279A/zh active Pending
- 1998-06-08 WO PCT/IB1998/000883 patent/WO1998056360A2/en active IP Right Grant
- 1998-06-08 KR KR10-1999-7011668A patent/KR100400053B1/ko active IP Right Review Request
- 1998-06-08 PT PT98921690T patent/PT989848E/pt unknown
- 1998-06-08 CA CA002293815A patent/CA2293815C/en not_active Expired - Lifetime
- 1998-06-08 BR BR9810027-0A patent/BR9810027A/pt not_active Application Discontinuation
- 1998-06-08 RU RU2000100940/14A patent/RU2193880C2/ru active
- 1998-06-08 DE DE69826660T patent/DE69826660T2/de not_active Expired - Lifetime
- 1998-06-08 TR TR2000/00111T patent/TR200000111T2/xx unknown
- 1998-06-08 SG SG200200225A patent/SG108292A1/en unknown
- 1998-06-08 AU AU74460/98A patent/AU729912B2/en not_active Expired
- 1998-06-08 AT AT98921690T patent/ATE277606T1/de active
- 1998-06-10 US US09/095,322 patent/US6165513A/en not_active Expired - Lifetime
- 1998-06-10 PE PE1998000490A patent/PE82999A1/es not_active IP Right Cessation
- 1998-06-10 ZA ZA985010A patent/ZA985010B/xx unknown
- 1998-06-11 MY MYPI98002615A patent/MY127526A/en unknown
- 1998-06-11 CO CO98033551A patent/CO4940409A1/es unknown
- 1998-06-11 AR ARP980102774A patent/AR027158A1/es not_active Application Discontinuation
- 1998-07-02 TW TW087110727A patent/TW542725B/zh not_active IP Right Cessation
-
1999
- 1999-12-09 IL IL133405A patent/IL133405A/en not_active IP Right Cessation
- 1999-12-10 NO NO19996116A patent/NO996116L/no not_active Application Discontinuation
-
2000
- 2000-09-26 HK HK00106110A patent/HK1028187A1/xx not_active IP Right Cessation
- 2000-10-23 US US09/694,799 patent/US6569460B1/en not_active Expired - Lifetime
-
2003
- 2003-03-28 US US10/401,352 patent/US20030211156A1/en not_active Abandoned
-
2006
- 2006-12-01 US US11/607,241 patent/US20070071822A1/en not_active Abandoned
-
2010
- 2010-06-02 JP JP2010127107A patent/JP5229641B2/ja not_active Expired - Fee Related
-
2012
- 2012-12-04 JP JP2012265555A patent/JP2013067642A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4940409A1 (es) | Tableta cubierta con pelicula para seguridad mejorada del tracto gastrointestinal superior | |
DE69231313D1 (de) | Risedronat enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe | |
BR9814378A (pt) | Forma de dosagem de liberação prolongada farmacêutica revestida entérica de um inibidor de h+, k+-atpase, processos para a manufatura da mesma, para melhorar a inibição de secreção de ácido gástrico, para melhorar o efeito terapêutico no tratamento de distúrbios gastrointentinais, para receber um perfil de plasma prolongado de um inibidor da h+, k+-atpase, e, usos de uma composição farmacêutica e de inibidor da h+, k+-atpase | |
RU94027277A (ru) | Препараты ризедроната с замедленным выделением, способ лечения | |
BR9916224A (pt) | Forma de dosagem farmacêutica oral, processos para a manufatura de uma forma de dosagem fixa, para o tratamento e a profilaxia de distúrbios gastrintestinais e para evitar efeitos colaterias gastrintestinais, uso de uma forma de dosagem, combinação, e, embalagem tipo ampola | |
ATE340563T1 (de) | DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT | |
RU2000100940A (ru) | Покрытая пленкой таблетка улучшенной безопасности для верхних отделов желудочно-кишечного тракта | |
WO2002098352A3 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs | |
BG105173A (en) | Novel salt form of pantoprazole | |
HUP0301390A2 (hu) | Valzartánt tartalmazó orális gyógyászati készítmény | |
BR9807992A (pt) | Comprimidos para engolir os quais compreendem paracetamol | |
RU2001107149A (ru) | Тауролидин и/или таурултам против инфекционной язвенной болезни или инфекционного гастрита | |
HUP0400127A2 (hu) | Paracetamolt tartalmazó lenyelhető tabletta | |
ATE253369T1 (de) | Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung | |
US20060141027A1 (en) | Sublingual administration of non-steroidal anti-inflammatory pharmacological substances | |
HUP0400495A2 (hu) | Apomorfin szájnyálkahártyán keresztül történő adagolására szolgáló orális készítmény | |
JP2900056B2 (ja) | 非ステロイド抗炎症剤により生じる胃疾患の予防用医薬組成物 | |
JPS5462327A (en) | Remedy for dna virus infectious disease | |
TH31107B (th) | ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน | |
RU96121556A (ru) | Фармацевтические составы, содержащие ранитидин в низких дозах | |
TH61079A (th) | ยาเม็ดเคลือบฟิล์มสำหรับความปลอดภัยที่ดีขึ้นสำหรับทางเดินกระเพาะลำไส้ตอนบน |